Johnson & Johnson headquarters in New Brunswick, N.J.
Mel Evans | AP
Johnson & Johnson on Wednesday reported fiscal fourth-quarter profit that beat Wall Street’s expectations but missed slightly on revenue.
J&J’s stock fell by about 1.6% just before the opening bell.
“We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our pharmaceutical business, accelerating performance in our medical devices business and improved profitability in our consumer business,” J&J Chairman and CEO Alex Gorsky said in a press release.
Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv:
- Adjusted earnings per share:…